Economic Times | GSK taps UK firm for 'beyond antibodies' drug technology Reuters By P.J. Huffstutter. LONDON | Tue Jul 9, 2013 7:51pm EDT. LONDON (Reuters) - GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways ... Cutting Edge Cancer Therapy From Immunocore Receives $212M In Funding ... |
